Regulatory Alerts, Diabetes and other endocrinal, nutritional and metabolic conditions, Endocrinological conditions other than diabetes
Drug Safety Update: alkindi (hydrocortisone granules)
MHRA warns of risk of acute adrenal insufficiency in children when switching from hydrocortisone tablet formulations to granules.